Clonal isolation and characterization of bone marrow stromal cells from patients with osteoarthritis.

The demand for treatment strategies for damaged musculoskeletal tissue is continuously growing, especially with the increasing number of older people with degenerative diseases of the skeletal system such as osteoarthritis (OA). Because depletion of multipotent cells has been implicated in degenerative joint diseases, cell-based therapies have been proposed for tissue regeneration, especially for cartilage repair. The aim of the present study is to focus on the possibility of deriving and expanding multipotential mesenchymal stem cells (MSCs) from bone marrow samples of patients with OA by characterizing MSCs at the single cell level. Single-cell clonal cultures were established in 96-well plates by limiting dilution of bone marrow stromal cells (BMSCs) from three patients with OA. Fourteen clones were established for subsequent characterization. There was a wide variation in cell doubling times, with the time taken to reach 20 population doublings ranging from 37 days to more than 100 days. The clones were grouped into fast-growing and slow-growing clones. All except one of the fast-growing stem cell clones were tripotential. However, the slow-growing clones showed limited differentiation potential and morphological changes associated with cellular senescence with extended duration in culture. Flow cytometric analysis indicated a strong need to investigate for novel cell-surface characteristic markers of BMSCs because there was no obvious difference in the expression of the selected characteristic BMSC cell surface markers CD29, CD44, CD90, CD105, and CD166 between fast-growing and slow-growing clones. This study has demonstrated the existence of a fast-growing multipotential MSC population from bone marrow samples of patients with OA. Therefore, despite a supposedly smaller stem cell compartment in these patients, we demonstrate here that they can still yield a potentially therapeutically useful source of syngeneic MSCs.

[1]  R. Class,et al.  Propagation and senescence of human marrow stromal cells in culture: a simple colony‐forming assay identifies samples with the greatest potential to propagate and differentiate , 1999, British journal of haematology.

[2]  Ching-Chuan Jiang,et al.  Multipotential Mesenchymal Stem Cells from Femoral Bone Marrow Near the Site of Osteonecrosis , 2003, Stem cells.

[3]  D J Prockop,et al.  Identification of a subpopulation of rapidly self-renewing and multipotential adult stem cells in colonies of human marrow stromal cells , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[4]  H. J. Baker,et al.  Isolation and characterization of multipotential mesenchymal stem cells from feline bone marrow. , 2002, Experimental hematology.

[5]  R Cancedda,et al.  Clonal mesenchymal progenitors from human bone marrow differentiate in vitro according to a hierarchical model. , 2000, Journal of cell science.

[6]  H. L. Roh,et al.  Alterations in the differentiation ability of mesenchymal stem cells in patients with nontraumatic osteonecrosis of the femoral head: Comparative analysis according to the risk factor , 2006, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[7]  S. Gronthos,et al.  Molecular and cellular characterisation of highly purified stromal stem cells derived from human bone marrow , 2003, Journal of Cell Science.

[8]  Dietmar W Hutmacher,et al.  Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model. , 2006, Tissue engineering.

[9]  R. Cancedda,et al.  Microenvironment and stem properties of bone marrow‐derived mesenchymal cells , 2001, Wound repair and regeneration : official publication of the Wound Healing Society [and] the European Tissue Repair Society.

[10]  R. Gary,et al.  Quantitative assay of senescence-associated beta-galactosidase activity in mammalian cell extracts. , 2005, Analytical biochemistry.

[11]  M. Lotz,et al.  Identification of mesenchymal progenitor cells in normal and osteoarthritic human articular cartilage. , 2004, Arthritis and rheumatism.

[12]  F. Luyten Mesenchymal stem cells in osteoarthritis , 2004, Current opinion in rheumatology.

[13]  Christian Krettek,et al.  Modulation of proliferation and differentiation of human bone marrow stromal cells by fibroblast growth factor 2: potential implications for tissue engineering of tendons and ligaments. , 2005, Tissue engineering.

[14]  M. Pittenger,et al.  Multilineage potential of adult human mesenchymal stem cells. , 1999, Science.

[15]  H. Broxmeyer,et al.  Characterization of human bone marrow fibroblast colony-forming cells (CFU-F) and their progeny. , 1980, Blood.

[16]  Kenneth Dixon,et al.  Reduced chondrogenic and adipogenic activity of mesenchymal stem cells from patients with advanced osteoarthritis. , 2002, Arthritis and rheumatism.

[17]  R. Tuan,et al.  Adult mesenchymal stem cells: characterization, differentiation, and application in cell and gene therapy , 2004, Journal of cellular and molecular medicine.

[18]  Rodolfo Quarto,et al.  Ex vivo enrichment of mesenchymal cell progenitors by fibroblast growth factor 2. , 2003, Experimental cell research.

[19]  R. Oreffo,et al.  Skeletal progenitor cells and ageing human populations. , 1998, Clinical science.

[20]  M. Mastrogiacomo,et al.  Proliferation kinetics and differentiation potential of ex vivo expanded human bone marrow stromal cells: Implications for their use in cell therapy. , 2000, Experimental hematology.

[21]  P. Emery,et al.  Enumeration and phenotypic characterization of synovial fluid multipotential mesenchymal progenitor cells in inflammatory and degenerative arthritis. , 2004, Arthritis and rheumatism.

[22]  R. Quarto,et al.  Bone progenitor cell deficits and the age-associated decline in bone repair capacity , 1995, Calcified Tissue International.

[23]  Yilin Cao,et al.  Repair of experimental alveolar bone defects by tissue-engineered bone. , 2006, Tissue engineering.